NLRP3 and colitis: Our study herein provides molecular insights into how the IL-10/IL-10R signaling axis regulates NLRP3 inflammasome activation in macrophages during acute and chronic LPS/ATP stimulation, and helps to identify novel targets that could be exploited to treat colitis.